Changes in tension of immunity to pertussis by time of immunization
Year: 2023, volume 19 Issue: №1 Pages: 51-56
Heading: Pediatrics Article type: Original article
Authors: Demurcheva I.V., Bezrodnova S.M., Baturin V.A., Kravchenko O.O.
Organization: Stavropol State Medical University
Heading: Pediatrics Article type: Original article
Authors: Demurcheva I.V., Bezrodnova S.M., Baturin V.A., Kravchenko O.O.
Organization: Stavropol State Medical University
Summary:
Abstract. Objective: to identify the features of post-vaccination immunity to whooping cough, the state of immuno-logical reactivity in children of the Stavropol Territory. Material and methods. A comprehensive clinical and laboratory examination of 242 children aged 1 to 17 years was carried out. Serological examination of children was carried out at different times after revaccination, as well as an analysis of the parameters of the immune system in children of this age group. Results. A study of the level of immunity tension in children of early and school age showed that a low level of anti-pertussis antibodies was detected in 55% of children already 2-3 years after immunization, meaning that these children were at risk of pertussis, while protective titers of anti-pertussis antibodies were detected only in 34%, and high titers 11% of children. Conclusion. Children vaccinated in anamnesis in Stavropol Territory lose specific antibodies 3 years after the initial vaccination complex.
Bibliography:
1. Nguyen VTN, Simon L. Pertussis: the whooping cough. Prim Care. 2018; 45 (3): 423-31.
2. Mindlina AYa, Polybin RV. On the need to improve the tactics of pertussis immunoprophylaxis. Pulmonology. 2016; 26 (5): 560-9.
3. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2018: State report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2020; 299 p.
4. Diavatopoulos DA, Edward KM. Edward what is wrong with pertussis vaccine immunity? Why immunological memory to pertussis is failing. Cold Spring Harb Perspect Biol. 2017; 9 (12): a029553.
5. Nieves DJ, Heininger U. Bordetella pertussis. Microbiol Spectr. 2016; 4 (3). DOI: 10.1128/microbiolspec.
6. Novikova DA, Tkachenko NE. Combined vaccine — effective and safe protection from five controlled infections. Pediatric Pharmacology. 2014; 11 (3): 107-10.
7. Pertussis vaccines: WHO position paper. 2015; 90 (35): 433-60.
8. Wendelboe AM, Hudgens MG, Poole Ch, Rie AV. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerging Themes in Epidemiology. 2007; 4 (1): 15.
9. Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the United States. Pediatrics. 2015; 136 (4): 635-41.
10. StepenkoAV, MindlinaAY. Pertussis epidemic process risk management: missed opportunities and new prospects. Medical Almanac. 2017; 49 (4): 83-6.
11. Public Health Agency of Canada. Canadian National Report on Immunization. Can Commun Dis Rep. 2006; 32 (S3): 1-44.
12. Skoff TH, Cohn AC, Clark ТА, et al. Early impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med. 2012; 166 (4): 344-9.
13. Quinn HE, Mclntyre PB. The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia. Bulletin of the World Health Organization. 2011; (89): 666-74.
| Attachment | Size |
|---|---|
| 2023_01_51-56.pdf | 361.61 KB |
Русский
English